KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Neogenomics (NEO) EPS (Basic): 2009-2024

Historic EPS (Basic) for Neogenomics (NEO) over the last 16 years, with Dec 2024 value amounting to -$0.62.

  • Neogenomics' EPS (Basic) fell 50.00% to -$0.21 in Q3 2025 from the same period last year, while for Sep 2025 it was -$0.88, marking a year-over-year decrease of 44.26%. This contributed to the annual value of -$0.62 for FY2024, which is 11.43% up from last year.
  • According to the latest figures from FY2024, Neogenomics' EPS (Basic) is -$0.62, which was up 11.43% from -$0.70 recorded in FY2023.
  • Neogenomics' 5-year EPS (Basic) high stood at $0.04 for FY2020, and its period low was -$1.16 during FY2022.
  • In the last 3 years, Neogenomics' EPS (Basic) had a median value of -$0.70 in 2023 and averaged -$0.83.
  • Its EPS (Basic) has fluctuated over the past 5 years, first crashed by 1,557.14% in 2022, then skyrocketed by 39.66% in 2023.
  • Yearly analysis of 5 years shows Neogenomics' EPS (Basic) stood at $0.04 in 2020, then plummeted by 275.00% to -$0.07 in 2021, then plummeted by 1,557.14% to -$1.16 in 2022, then spiked by 39.66% to -$0.70 in 2023, then climbed by 11.43% to -$0.62 in 2024.